Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET
Company Participants
Andrea Christopher - Head, Corporate Communications and Investor Relations
Peter Greenleaf - President, Chief Executive Officer and Director
Joe Miller - Chief Financial Officer
Greg Keenan - Chief Medical Officer
Conference Call Participants
Vishwesh Shah - TD Cowen
Olivia Brayer - Cantor Fitzgerald
Farzin Haque - Jefferies
Will Soghikian - Leerink Partners
Ed Arce - H.C. Wainwright
Operator
Greetings, and welcome to the Aurinia Pharmaceuticals Fourth Quarter and Full-Year 2024 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder this conference is being recorded.
I would now like to turn the conference over to your host, Andrea Christopher, Head of Corporate Communications and Investor Relations for Aurinia. Thank you. You may begin.
Andrea Christopher
Thank you, operator, and thank you to everyone for joining today's call and webcast. Joining me on the call this morning are Peter Greenleaf, Aurinia's President and Chief Executive Officer; Joe Miller, Aurinia's Chief Financial Officer; and Dr. Greg Keenan, Aurinia's Chief Medical Officer.
Today, we will review and discuss Aurinia's fourth quarter and full-year 2024 financial results and provide an update on recent corporate progress, as communicated in the Company's press release and annual report on Form 10-K issued this morning. For more information, please refer to Aurinia's filings with the U.S. Securities and Exchange Commission and Canadian securities authorities, which are also available on Aurinia's website at auriniapharma.com.
During today's call, Aurinia may make forward-looking statements based on current expectations. These forward-looking statements are subject to a number of significant risks and uncertainties, and actual results may differ materially. For a discussion of factors that could affect Aurinia's future financial results and business, please refer to
- Read more current AUPH analysis and news
- View all earnings call transcripts